Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout (NCT05522504) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
China600 participantsStarted 2022-09-15
Plain-language summary
The purpose of this study is to evaluate whether immune cells and their subtypes in peripheral blood affects the asymptomatic hyperuricemia, gout flare, intercritical gout and advanced gout.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* gout flare:diagnosis with gout flare at this hospital according to the criteria approved by the ACR Board of Directors and the EULAR Executive Committee in 2015
* intercritical gout: remission of gout patients were classified into intercritical gout group without tophi, chronic gouty arthritis, or imaging erosion(All of these gout remission patients underwent dual-energy CT test within one month, and were detected to have MSU crystal deposition in local joints)
* advanced gout: gout remission patients were classified into advanced gout group characterized by tophi, chronic gouty arthritis, or imaging erosion(All of these gout remission patients underwent dual-energy CT test within one month, and were detected to have MSU crystal deposition in local joints)
* asymptomatic hyperuricemia: hyperuricemia in men was defined as SUA ≥ 420 mmol/L without any complications
Exclusion Criteria:
* primary osteoarticular diseases
* unwilling participation in the study
* corticosteroids or indomethacin use in the past 3 months;
* septic arthritis or another joint disease (such as rheumatoid arthritis);
* impaired renal function (creatinine clearance \<30 mL/min) and other conditions which may increase the level of blood uric acid